Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

2(40.0%)

5Total

N/A(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06782204Phase 1Completed

Variability of Sulfotransferase Activity in Humans: an Approach to Improve Predictive Drug Response Part II: Analysis of Interindividual Variation in Hypertensive Patients

Role: lead

NCT06702150Not ApplicableCompleted

Nursing Model and Health Outcomes of Elderly People with Multimorbidity: a Quasi-experimental Study

Role: lead

NCT04646902Unknown

Kynurenine/Tryptophan Ratio in Hypertension Associated to Obstructive Sleep Apnea

Role: collaborator

NCT05391646Not Yet Recruiting

Pulmonary Embolism Registry

Role: collaborator

NCT04593212Unknown

Assessment of Microcirculatory Dysfunction in Septic Shock Patients by OCTA

Role: lead

NCT05954689Not ApplicableUnknown

Femoral Artery Block for Reduction of Tourniquet Induced Hypertension

Role: lead

NCT03182595Phase 1Completed

Variability of Sulfotransferase 1A1 Activity in Humans: an Approach to Improve Predictive Drug Response - Part I: Analysis of Intraindividual Variation in Healthy Adults

Role: lead

NCT02803411Unknown

Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)

Role: collaborator

NCT02502877Not ApplicableCompleted

Core Temperature Variations During Midazolam vs Propofol Sedation for Neuraxial Anesthesia

Role: lead

All 9 trials loaded